Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorhexidine 0.12% vs 2% for oral decolonization in ICU patients
NCT03442023Phase 3Unknown
- Sponsor
- Universidad de Guanajuato
- Start
- Feb 2019
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of chlorhexidine in ventilator-associated pneumonia (VAP), sponsored by Universidad de Guanajuato. Status: unknown.
02
Drugs
chlorhexidine
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on NCT03442023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03442023.